SSRI use in late pregnancy increases risk of internalizing disorders in preschool offspring, no risk to development

Abstract

Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) has no substantial increased risk on children's behavioral, emotional, and social development, according to a study that followed mother‐child dyads from pregnancy through age 5 of the child. There was a risk for great anxious/depressed behaviors in the children when the SSRI was taken during late pregnancy only, but unmeasured confounding can't be ruled out, the researchers concluded.